Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.
D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D003024:Clozapine / Q000494:pharmacology*; D003984:Dibenzazepines / Q000494:pharmacology*; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000613:Aminobutyrates; D003984:Dibenzazepines; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase; D003024:Clozapine; D006220:Haloperidol